{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T22:08:35Z","timestamp":1792015715352,"version":"4.4.0"},"reference-count":36,"publisher":"Elsevier BV","issue":"13","license":[{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["cghjournal.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Gastroenterology and Hepatology"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1016\/j.cgh.2019.03.040","type":"journal-article","created":{"date-parts":[[2019,3,29]],"date-time":"2019-03-29T12:30:32Z","timestamp":1553862632000},"page":"2704-2712.e3","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":83,"title":["Incidence of Immune-Mediated Inflammatory Diseases Among Patients With Inflammatory Bowel Diseases in Denmark"],"prefix":"10.1016","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3312-5139","authenticated-orcid":false,"given":"Johan","family":"Burisch","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tine","family":"Jess","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Egeberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cgh.2019.03.040_bib1","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.crohns.2013.01.010","article-title":"The burden of inflammatory bowel disease in Europe","volume":"7","author":"Burisch","year":"2013","journal-title":"J\u00a0Crohn\u2019s Colitis"},{"key":"10.1016\/j.cgh.2019.03.040_bib2","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1053\/j.gastro.2005.06.021","article-title":"The clustering of other chronic inflammatory diseases in inflammatory bowel disease: a population-based study","volume":"129","author":"Bernstein","year":"2005","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2019.03.040_bib3","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1111\/apt.13940","article-title":"The impact of co-existing immune-mediated diseases on phenotype and outcomes in inflammatory bowel diseases","volume":"45","author":"Conway","year":"2017","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.cgh.2019.03.040_bib4","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1002\/ibd.20406","article-title":"Autoimmune disease concomitance among inflammatory bowel disease patients in the United States, 2001-2002","volume":"14","author":"Cohen","year":"2008","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.cgh.2019.03.040_bib5","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1136\/gutjnl-2016-311785","article-title":"Preclinical disease and preventive strategies in IBD: perspectives, challenges and opportunities","volume":"65","author":"Torres","year":"2016","journal-title":"Gut"},{"key":"10.1016\/j.cgh.2019.03.040_bib6","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1136\/gut.2009.199679","article-title":"New IBD genetics: common pathways with other diseases","volume":"60","author":"Lees","year":"2011","journal-title":"Gut"},{"key":"10.1016\/j.cgh.2019.03.040_bib7","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1038\/nrg3502","article-title":"Genetic insights into common pathways and complex relationships among immune-mediated diseases","volume":"14","author":"Parkes","year":"2013","journal-title":"Nat Rev Genet"},{"key":"10.1016\/j.cgh.2019.03.040_bib8","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.3389\/fmicb.2016.01081","article-title":"The gut microbiota in immune-mediated inflammatory diseases","volume":"7","author":"Forbes","year":"2016","journal-title":"Front Microbiol"},{"key":"10.1016\/j.cgh.2019.03.040_bib9","first-page":"441","article-title":"The Danish Civil Registration System. a cohort of eight million persons","volume":"53","author":"Pedersen","year":"2006","journal-title":"Dan Med Bull"},{"key":"10.1016\/j.cgh.2019.03.040_bib10","first-page":"263","article-title":"The Danish National Hospital Register. A valuable source of data for modern health sciences","volume":"46","author":"Andersen","year":"1999","journal-title":"Dan Med Bull"},{"key":"10.1016\/j.cgh.2019.03.040_bib11","doi-asserted-by":"crossref","first-page":"154","DOI":"10.3109\/00365529609031980","article-title":"Assessment of the diagnoses of Crohn\u2019s disease and ulcerative colitis in a Danish hospital information system","volume":"31","author":"Fonager","year":"1996","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.cgh.2019.03.040_bib12","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1111\/apt.13971","article-title":"The incidence of inflammatory bowel disease in Denmark 1980-2013: a nationwide cohort study","volume":"45","author":"Lophaven","year":"2017","journal-title":"Aliment Pharmacol Ther"},{"issue":"7 suppl","key":"10.1016\/j.cgh.2019.03.040_bib13","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1177\/1403494810394717","article-title":"The Danish national prescription registry","volume":"39","author":"Kildemoes","year":"2011","journal-title":"Scand J Public Health"},{"issue":"7 suppl","key":"10.1016\/j.cgh.2019.03.040_bib14","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1177\/1403494811405098","article-title":"Danish registers on personal income and transfer payments","volume":"39","author":"Baadsgaard","year":"2011","journal-title":"Scand J Public Health"},{"key":"10.1016\/j.cgh.2019.03.040_bib15","doi-asserted-by":"crossref","first-page":"449","DOI":"10.2147\/CLEP.S91125","article-title":"The Danish National Patient Registry: a review of content, data quality, and research potential","volume":"7","author":"Schmidt","year":"2015","journal-title":"Clin Epidemiol"},{"key":"10.1016\/j.cgh.2019.03.040_bib16","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1111\/j.1600-0404.2011.01558.x","article-title":"Evaluating the use and limitations of the Danish National Patient Register in register-based research using an example of multiple sclerosis","volume":"125","author":"Mason","year":"2012","journal-title":"Acta Neurol Scand"},{"key":"10.1016\/j.cgh.2019.03.040_bib17","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.jid.2018.07.029","article-title":"Incidence and risk of inflammatory bowel disease in patients with psoriasis - a nationwide 20-year cohort study","volume":"139","author":"Egeberg","year":"2019","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.cgh.2019.03.040_bib18","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1136\/annrheumdis-2016-210963","article-title":"Incidence and prevalence of psoriatic arthritis in Denmark: a nationwide register linkage study","volume":"76","author":"Egeberg","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.cgh.2019.03.040_bib19","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1007\/s10654-004-1025-0","article-title":"Validity of rheumatoid arthritis diagnoses in the Danish National Patient Registry","volume":"19","author":"Pedersen","year":"2004","journal-title":"Eur J Epidemiol"},{"key":"10.1016\/j.cgh.2019.03.040_bib20","doi-asserted-by":"crossref","first-page":"789","DOI":"10.2147\/CLEP.S122300","article-title":"Validation of celiac disease diagnoses recorded in the Danish National Patient Register using duodenal biopsies, celiac disease-specific antibodies, and human leukocyte-antigen genotypes","volume":"8","author":"Dydensborg Sander","year":"2016","journal-title":"Clin Epidemiol"},{"key":"10.1016\/j.cgh.2019.03.040_bib21","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1186\/1471-2288-11-83","article-title":"The predictive value of ICD-10 diagnostic coding used to assess Charlson comorbidity index conditions in the population-based Danish National Registry of Patients","volume":"11","author":"Thygesen","year":"2011","journal-title":"BMC Med Res Methodol"},{"key":"10.1016\/j.cgh.2019.03.040_bib22","doi-asserted-by":"crossref","first-page":"67","DOI":"10.2147\/CLEP.S6875","article-title":"Validity of asthma diagnoses in the Danish National Registry of Patients, including an assessment of impact of misclassification on risk estimates in an actual dataset","volume":"2","author":"Jensen","year":"2010","journal-title":"Clin Epidemiol"},{"key":"10.1016\/j.cgh.2019.03.040_bib23","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1089\/105072502760043503","article-title":"Fractures in patients with hyperthyroidism and hypothyroidism: a nationwide follow-up study in 16,249 patients","volume":"12","author":"Vestergaard","year":"2002","journal-title":"Thyroid"},{"key":"10.1016\/j.cgh.2019.03.040_bib24","doi-asserted-by":"crossref","first-page":"1990","DOI":"10.1001\/jamainternmed.2015.5396","article-title":"Risk of demyelinating diseases in the central nervous system in patients with inflammatory bowel disease treated with tumor necrosis factor inhibitors","volume":"175","author":"Nyboe Andersen","year":"2015","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.cgh.2019.03.040_bib25","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1136\/gutjnl-2018-316937","article-title":"Association between inflammatory bowel disease and Parkinson\u2019s disease: seek and you shall find?","volume":"68","author":"Weimers","year":"2019","journal-title":"Gut"},{"key":"10.1016\/j.cgh.2019.03.040_bib26","doi-asserted-by":"crossref","first-page":"6137","DOI":"10.3748\/wjg.v23.i33.6137","article-title":"Patients with inflammatory bowel disease have increased risk of autoimmune and inflammatory diseases","volume":"23","author":"Halling","year":"2017","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.cgh.2019.03.040_bib27","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1185\/030079906X104641","article-title":"Co-occurrence and comorbidities in patients with immune-mediated inflammatory disorders: an exploration using US healthcare claims data, 2001\u20132002","volume":"22","author":"Robinson","year":"2006","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.cgh.2019.03.040_bib28","doi-asserted-by":"crossref","first-page":"e92","DOI":"10.2500\/aap.2015.36.3869","article-title":"Association of inflammatory bowel disease with asthma risk: a nationwide cohort study","volume":"36","author":"Peng","year":"2015","journal-title":"Allergy Asthma Proc"},{"key":"10.1016\/j.cgh.2019.03.040_bib29","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1093\/ecco-jcc\/jjv193","article-title":"Inflammatory bowel disease and the risk of autoimmune diseases","volume":"10","author":"Wilson","year":"2016","journal-title":"J\u00a0Crohns Colitis"},{"key":"10.1016\/j.cgh.2019.03.040_bib30","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1053\/j.gastro.2005.06.022","article-title":"Increased risk for demyelinating diseases in patients with inflammatory bowel disease","volume":"129","author":"Gupta","year":"2005","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2019.03.040_bib31","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1177\/1352458513515081","article-title":"Milder multiple sclerosis course in patients with concomitant inflammatory bowel disease","volume":"20","author":"Z\u00e9phir","year":"2014","journal-title":"Mult Scler"},{"key":"10.1016\/j.cgh.2019.03.040_bib32","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1097\/MEG.0000000000000992","article-title":"Prevalence, incidence, and autoimmune comorbidities of celiac disease: a nation-wide, population-based study in Denmark from 1977 to 2016","volume":"30","author":"Grode","year":"2018","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2019.03.040_bib33","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1136\/annrheumdis-2012-201969","article-title":"Incidences of overall and site specific cancers in TNF\u03b1 inhibitor treated patients with rheumatoid arthritis and other arthritides - a follow-up study from the DANBIO Registry","volume":"72","author":"Dreyer","year":"2013","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.cgh.2019.03.040_bib34","doi-asserted-by":"crossref","first-page":"1794","DOI":"10.1097\/MIB.0000000000000429","article-title":"Chronological order of appearance of extraintestinal manifestations relative to the time of IBD diagnosis in the Swiss Inflammatory Bowel Disease Cohort","volume":"21","author":"Vavricka","year":"2015","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.cgh.2019.03.040_bib35","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1007\/s12325-018-0678-0","article-title":"Adalimumab reduces extraintestinal manifestations in patients with Crohn\u2019s disease: a pooled analysis of 11 clinical studies","volume":"35","author":"Louis","year":"2018","journal-title":"Adv Ther"},{"key":"10.1016\/j.cgh.2019.03.040_bib36","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1093\/ecco-jcc\/jjy061","article-title":"Phenotype and clinical course of inflammatory bowel disease with co-existent celiac disease","volume":"12","author":"Tse","year":"2018","journal-title":"J\u00a0Crohns Colitis"}],"container-title":["Clinical Gastroenterology and Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1542356519303052?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1542356519303052?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T05:27:18Z","timestamp":1761542838000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1542356519303052"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12]]},"references-count":36,"journal-issue":{"issue":"13","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["S1542356519303052"],"URL":"https:\/\/doi.org\/10.1016\/j.cgh.2019.03.040","relation":{},"ISSN":["1542-3565"],"issn-type":[{"value":"1542-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2019,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Incidence of Immune-Mediated Inflammatory Diseases Among Patients With Inflammatory Bowel Diseases in Denmark","name":"articletitle","label":"Article Title"},{"value":"Clinical Gastroenterology and Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cgh.2019.03.040","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 by the AGA Institute","name":"copyright","label":"Copyright"}]}}